Expert Perspectives on Novel Drug Delivery Systems in the Management of Pediatric ADHD

Digital therapeutics help kids build emotional regulation and coping skills, supporting pediatric care while waiting for specialized mental health services.

Each year in this country, physicians prescribe medications to treat ADHD in nearly 3 million children. The safety of these agents has been the subject of some debate.

The once daily extended-release oral suspension with nighttime dosing is approved to treat ADHD as a monotherapy or as an adjunctive therapy to approved CNS stimulant medications.

New international findings show BPD diagnosis in teenaged years may be a critical indicator of subsequent mental disorder into young adulthood.

According to a recent study, young adults (aged 18-19 years) discontinue ADHD medication the most, compared to younger children.

To assess the role of familial factors, investigators analyzed data for a family-based group created from another Swedish national register that included 833,172 individuals without ADHD with different levels of relatedness to the individuals with ADHD and a group of matched controls.